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Introduction
In 1883, Jean Alfred Fournier1 described an idiopathic
rapidly progressing necrotizing fasciitis of the penis and
scrotum in five young males. This synergistic necrotizing
fasciitis of the perineal, genital or perianal regions was
actually first described by Baurienne in 17642. Since
Fournier’s discovery, this disease has been found to affect
not only young males but also all ages from newborn to
elderly patients in modern medical practice3,4. In the
study of Stephens et al.5, the average age of the patients
increased from 40 years historically to 50 years after
1979. Even in present clinical practice, a mortality rate
of up to 50%6,7 in Fournier’s gangrene (FG) still remains
a serious concern. Some studies8–10 have revealed that
patients with FG who are older than 60 years have a
higher mortality rate compared with patients with FG
who are younger than 60 years (50% mortality after 60
years). In this article, we review the etiology, associated
conditions, manifestation, diagnosis, management and
prognosis in elderly patients with FG.
Etiology and Associated Conditions
In a review article of 1,726 cases by Eke11 in 2000, the
causes of FG included dermatologic (24%), colorectal
(21%), genitourologic (19%) and idiopathic (36%) sources.
Most other review articles have observed similar
results12–15. Common dermatologic causes include elec-
tive skin surgical procedures, skin abscesses, and pressure
sores2. Frequent colorectal etiologies include anorectal
infections, ischiorectal abscesses, colon perforations, and
some routine anorectal procedures (rectal biopsy, anal
dilatation or hemorrhoidal banding)2,16–19. Commonly
reported genitourologic conditions include urethral
stricture, trauma from an indwelling Foley catheter, ure-
thral calculi, and prostate biopsy2. In women, Bartholin
abscesses and vulval skin infections are the most com-
monly reported causes of FG20. Although improved
diagnostic tools have often demonstrated an underlying
etiology, a number of cases of idiopathic origin still
play a significant role in the pathogenesis of FG5,11,21.
In cases when an infection source cannot be readily
identified, a surgeon should further investigate the
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patient’s abdomen, because an infection from the
abdomen (diverticulitis, appendicitis, colon cancer,
Crohn’s disease, etc.)22–26 would significantly influence
subsequent treatment.
Despite varying etiologies, patients with FG are
usually observed to have a comorbid condition such as
diabetes mellitus (DM; 10–60% of cases)27, alcoholism,
immunosuppression (chemotherapy, steroids or post-
transplantation), leukemia or human immunodeficiency
virus infection. The possible mechanisms of DM patients
predisposing to FG include a higher number of bacte-
ria on the skin surface, defective phagocytosis, DM
neuropathy-induced bladder outlet obstruction with
subsequent urinary tract infection, and angiopathy-
induced tissue ischemia in infected areas28. Reported
occurrences of DM in patients with FG were 32%, 66%
and 50% in the studies of Clayton et al.4, Hejase et al.17
and Smith et al.2, respectively. The link between alcohol-
ism and FG was immunosuppression and poor hygiene.
Reported occurrences of alcoholism in FG were 51%,
66% and 40% in the studies of Clayton et al.4, Hejase 
et al.17, and Smith et al.2, respectively. In addition, mal-
nutrition and low socioeconomic status are also asso-
ciated with FG29. Filariasis has also been described as a
cause in some endemic areas30. Other conditions asso-
ciated with FG include prolonged hospitalization, malig-
nancy, and intravenous drug use2. All these associated
conditions and comorbidities result in varying degrees
of immunosuppression. The common feature in all these
comorbid conditions is decreased host resistance from
cellular immunity28.
In Taiwan, about 9.6% of the population is 65 years
of age or older31. The population demographics of
Taiwan are shifting to an increased proportion of the
elderly. By the year 2020, over 14% of the Taiwanese
population will probably fall into this age range31. There
is clear evidence that elderly patients experience a sig-
nificantly increased incidence of severe sepsis from
infection32. Infection in elderly patients usually has a
high mortality and morbidity rate in spite of modern
medical care. Factors predisposing the elderly to infec-
tion include diminishing immunity, inadequate social
support, underlying comorbid situations, and physio-
logic changes that accompany aging (e.g., malnutrition,
poor circulation). Although Franceschi et al.33 believed
that healthy elderly subjects could have strong immune
responses, the diminishing immune system likely plays
a crucial role in the vulnerability of the elderly to
infections such as FG. On the other hand, many factors
also increase the risk of FG in the elderly and are not
necessarily associated with diminishing immunity. The
elderly usually exhibit atypical symptoms compared
with younger patients, making immediate and accurate
diagnosis difficult. Furthermore, coexisting chronic ill-
nesses (congestive heart failure, DM) in the elderly may
also distort the typical symptoms of FG. Fever may also
be delayed in the elderly. Jarrett et al.34 compared de-
mented and dependent patients with nondemented and
independent counterparts, concluding that the former
group was likely to have more complicated hospital stays
and exhibit confusion, delirium and dehydration.
Manifestation
Clinical observations of FG showed male predominance
and a mean age of more than 50 years35. The described
manifestation of FG is extremely variable. Clayton et al.4
reported that scrotal swelling and smelly odors were
noted in all their 57 patients with FG of the male gen-
italia. Fever and hyperemia were noted in 15% and 26%
of their patients, respectively. In the series of Baskin 
et al.19, they described pain or swelling in 100% of the
patients, fever in 19%, crepitus in 18%, skin necrosis in
10%, shock in 4% and delirium in 3%. Other cutaneous
manifestations consisted of cyanosis, bronzing, blister-
ing, and induration36. In summary, local symptomatic
manifestations are consistent with FG. However, systemic
symptoms are not necessarily consistent with FG.
Involved areas of FG may vary. In the study of Benizri
et al.18, involvement of the scrotum and penis occurred
in 50% and the perineum in 46% of FG patients. Locally
involved areas of FG were frequently reported to include
the abdominal wall, thorax, and extremities. Although
the original description emphasized an abrupt onset,
FG may present in an insidious way, especially in the
elderly37. FG usually initially presents with perineal or
perianal pain. The infective process of FG results in sub-
cutaneous blood vascular thromboembolization, which
consequently leads to skin gangrene. However, once
gangrene is established, pain is often diminished.
Afflicted individuals may have fever and general fatigue
for several days. Other signs and symptoms include
nonspecific abdominal pain, general symptoms of non-
specific infection, and septic signs. The clinical picture
becomes much clearer with worsening of cutaneous
inflammation and skin necrosis. Crepitus is usually
found on physical examination because of gas-forming
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bacteria within the infected bed. It is important for
physicians to recognize FG at an earlier stage, because
the cutaneous manifestation of FG has been likened to
“the tip of the iceberg” and it may present with trivial
cutaneous manifestation of the underlying severe
infection. Acute renal failure, acute respiratory distress
syndrome, pneumonia, intestinal bleeding, and heart
failure are the most commonly described systemic
complications38,39. Progression to single or multiorgan
failure may occur and is the usual cause of mortality36.
Diagnosis
Diagnosis is usually based primarily on clinical grounds.
With thorough clinical examination, the origin of the
infectious process can usually be found. Because delay
in treatment has a significant impact on poorer prog-
nosis, radiologic evaluation in equivocal cases can be
used to accelerate the diagnostic process somewhat9,40.
The extent of disease can be investigated by abdominal
echogram, computed tomography (CT) scan or magnetic
resonance imaging41. Amendola et al.42 concluded that
a preoperative CT scan is not essential in all patients
suspected to be infected with FG. However, when the
underlying infectious source is not clear, CT scans may
identify a retroperitoneal or intra-abdominal origin.
Plain film of the abdomen is also a useful tool43. A plain
film may demonstrate air in soft tissues. Although air
in soft tissues is not pathognomonic, it would alert
surgeons to the possibility of FG.
Occasionally, the diagnosis of FG must be well dif-
ferentiated from other acute scrotal conditions, such
as strangulated inguinoscrotal hernias, strangulated
Richter’s hernia, scrotal abscesses and scrotal cel-
lulites2,29. Some studies43–46 reported the discovery of
subcutaneous air by scrotal sonogram prior to crepitus
appearance, so scrotal sonograms have been used for
years in the diagnosis of FG. Scrotal sonograms can help
distinguish FG from intrascrotal pathology where scro-
tal pain, erythema, and swelling are commonly seen.
Most laboratory findings resulting from sepsis, and
not specific to FG, include thrombocytopenia, hyper-
glycemia, leukocytosis and anemia43. However, hypo-
calcemia due to bacteria lipase is thought to be an
important indicator of the early stage of FG47. The
interval between initial presentation and final diagno-
sis was reported to be 7.4 days in the series of Benizri
et al.18 and 4 days in the series of Lacran et al.48. This
long interval between presentation and diagnosis was
thought to be indicative of poor prognosis. Smith 
et al.2 suggested that the following two situations, when
encountered, should increase the likelihood of FG: (1)
when infectious processes do not respond well to antibi-
otics; and (2) when septic symptoms appear dispro-
portionate to scrotal cutaneous manifestations in the
early stage of infection.
Assessment of FG should also be focused on identi-
fying underlying comorbid diseases to make treatment
more effective. As a result, the following examinations
are recommended to exclude malignancies: urinalysis
and culture, retrograde urethrography, proctoscopy, and
biopsy18,38. Paty and Smith49 particularly emphasized
the role of retrograde urethrography and proctoscopy.
Preoperative proctoscopy is crucial in determining
whether to create a diverting stomy or not. Similarly, a
retrograde urethrogram may confirm the need for
suprapubic diversion if massive contrast extravasation
is found during examination. A retrograde urethrogram
should be obtained in all cases of FG preoperatively or
intraoperatively. A urinary tract imaging study and cys-
toscopy should be undertaken to identify a possible
source from genitourologic infection.
A bacteriologic examination with thorough screening
to identify the likely septic source is also necessary.
Biopsy of the involved tissue rarely helps the diagnosis
of FG, because the pathology always depicts nonspecific
findings such as dermal necrosis, thrombosis, and sub-
cutaneous tissue necrosis49. In the study of Paty and
Smith49, the gangrene has been estimated to proceed at
a rate of 2.5 cm per hour, so it is recommended not to
spend much time on performing too many investigations
on severely ill or elderly patients.
Management
The principles of management are hemodynamic sta-
bility, broad-spectrum antibiotics for all suspected
involved bacteria, careful treatment of underlying
comorbidities, and prompt debridement. Immediate
surgical debridement is the most important and effective
treatment.
Supportive methods
Aggressive, urgent intravenous fluid (crystalloid, colloid
or blood) resuscitation and careful correction of elec-
trolyte imbalance should be initiated immediately27.
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Critical care principles should be applied to patients
with FG. Adequate calorie and protein intake must be
ensured to support wound healing after surgical
debridement. Because parenteral nutrition may have
serious side effects, enteral feeding is preferred. Blood
and clotting factors may also be required. If FG is 
suspected, it is necessary to explore surgically as early
as possible.
Antibiotics
Because a mixture of microorganisms is usually found in
FG patients, triple-coverage broad-spectrum antibiotics
(penicillin for streptococcal species, metronidazole or
clindamycin for anaerobes, and third-generation ceph-
alosporins or aminoglycosides for Gram-negative aer-
obes) are usually recommended immediately before
culture results and sensitivities are obtained30. High
doses of antibiotics must be administered immediately
before surgery.
Local wound care agents
Some authors described local application of povidone-
iodine, sodium hypochlorite or hydrogen peroxide 
for postoperative wound treatment17,49. Naturally un-
processed honey can also be useful in postoperative
wound care, providing a promising acceleration of heal-
ing. The hypothesized mechanism of unprocessed honey
as a treatment includes production of oxygen, fluid
absorption, digestion of dead and necrotic tissue by
enzymes in the honey, cessation of the necrotic process,
and promotion of epithelial growth at the wound
edges17. Unprocessed honey also contains antimicrobial
agents. Both Efem29 and Hejase et al.17 enthusiastically
recommended the role of unprocessed honey. However,
further studies should be conducted to confirm the
usefulness of this agent.
Surgical management
FG has remained a surgical emergency even today, as
the infectious process can proceed rapidly within hours.
Ever since Meleney introduced debridement in patients
with FG in 1920s, this has remained the basis of manage-
ment of FG11. The patient should be put in the lithotomy
position, because this allows ready access to all perineal
structures. Laucks43 suggested that if a perineal source is
not found, physicians should suspect an abdominal
origin; in addition, exploratory laparotomy should be
considered. Minimally invasive laparoscopy can also be
considered as an adjunctive tool.
If necrotic testicles are found during debridement,
an intra-abdominal process, which leads to thrombosis
of the testicular artery, should be strongly suspected.
As testicles receive their blood supply from an abdom-
inal origin (nonperineal blood supply), the testicles are
always spared if disease affects the subcutaneous tissue
only23.
The goal of debridement is to remove all devitalized
tissues and prevent the infectious process from spread-
ing. Mere drainage of necrotic tissue without debride-
ment is associated with a very high mortality50. Laucks43
suggested excising tissue along the fascia planes until
viable tissue is encountered. However, because deep
fascia and muscle are rarely involved, it is usually not
essential to debride these areas. Because it is relatively
easy to separate diseased fascia from the underlying
healthy layers, this might help determine the extent of
excision. Surgeons always need to remove a large portion
of necrotic sites and leave a huge open wound to meet
the aforementioned criteria.
Although aggressive and prompt debridement results
in fewer repeated operations, repeated debridements
are frequently needed, with an average of two to four
debridements per patient19,38 to eradicate all remaining
infection sources due to the infiltrating nature of FG12,19.
After initial debridement, the wound must be carefully
monitored. If there is any doubt about tissue viability,
secondary exploration should be performed 24–48 hours
after the initial debridement to exclude ongoing necrosis.
This is particularly crucial while the patient’s systemic
situation has not been ameliorated after initial debride-
ment. If the septic signs do not improve after the initial
debridement, a missed intra- or retroperitoneal source
must be considered.
The use of fecal diversion or urinary diversion has
remained controversial. In the study of Caird et al.51,
most patients would preserve their testes and rectum.
Most cases would not require a concomitant diverting
colostomy; however, when extensive perineal debride-
ment is required or when gross sphincter infection or
rectal/colon perforation is present, many authors suggest
that it is essential to create a diverting colostomy14,18.
Similarly, when there is urine extravasation or peri-
urethral inflammation, urinary diversion may be con-
sidered49. This can usually be accomplished using a Foley
catheter. However, when urethra outflow obstruction is
present, suprapubic cystostomy is required17,38,52. On the
other hand, many authors emphasize the risk of infec-
tion associated with urinary drainage, recommending
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urinary diversion be limited only to perineal gangrene
of urologic origin35.
After adequate debridement, daily dressing changes
are needed to further remove any nonviable tissues
forming subsequently. Debridement may leave large
skin defects. Once the infection is cleared, wound healing
usually occurs without the need for reconstructive sur-
gery procedures. However, a split thickness skin graft or
other reconstructive procedures are sometimes needed
to cover large defects to prevent non-healing or wound
retraction10. The split thickness skin graft is the most
commonly used measure in current practice17,49.
Hyperbaric oxygen (HBO) therapy
In 1941, Ozrio De Almeida and Pecheco first suggested
the utilization of HBO18. Although HBO therapy is still
controversial, it has been regarded as an effective
adjuvant therapy in some patients53. It reduces systemic
toxicity and stops extension of necrotizing infection,
thus improving the outcome of patients. The postulated
mechanism is that HBO would exert an effect against
both clostridial and non-clostridial infections after
release of oxygen free radicals (peroxide and superox-
ide)10,12,54. However, this suggestion has not been con-
firmed in large randomized controlled trials. In addition,
HBO accelerates the phagocytic function of neutrophils
and consequently controls the infectious process. HBO
exerts beneficial effects on wounds by accelerating
angiogenesis and fibroblast proliferation53. HBO also
reduces edema by vasoconstriction and increases intra-
cellular transport of antibiotics. On the other hand, HBO
therapy did not provide significant benefits according
to other authors in terms of mortality and morbidity
rates14,15,17,55–57. Even though some authors support
the role of HBO in FG, HBO should not delay or replace
the role of definitive surgical debridement.
Prognosis
The mortality rate of patients with FG has been observed
to be 14–45%, with an average of 26% in published
reports14. In spite of modern medical measures, the
reported mortality rate is still over 40% in many stud-
ies2,52. The high mortality implies the aggressive nature
of the infection and the underlying debilitating situa-
tions. Moreover, in elderly patients, the mortality is even
higher. Some studies8–10 showed that patients older than
60 years have a higher mortality rate compared with
those who are younger than 60 years (50% mortality in
patients over 60 years).
In immunocompromised patients, the mortality was
also demonstrated to be higher58,59. Although DM is
frequently regarded as increasing mortality in FG, the
definitive relationship between underlying DM and
prognosis is still controversial60. Elliot et al.9 demon-
strated that only when DM was associated with renal
dysfunction or vascular impairment would it predispose
patients with FG to death.
Several negative prognostic factors were identified,
including advanced age4,7,18,19,43, primary anorectal
infections19,61, extensive involvement4, sepsis18, positive
blood culture18, female gender9, and delayed presen-
tation and treatment61. Debilitation and abnormal
homeostasis were also associated with unfavorable out-
comes2,61. Despite conflicting views, the extent of local
disease is not a negative predictor of FG7. Laor et al.7
has designed an FG severity index to identify prognostic
factors, and they found, as noted in other studies62,63,
that abnormal homeostasis was the most important
parameter predictive of outcome and not the extent
of disease or performance of surgical debridement.
Outcomes are primarily influenced by the timing
and adequacy of surgical debridement. Early aggressive
management is associated with a reduced mortality
rate. Reduction of mortality rate is not attributable to
antibiotics. Hospitalization is always prolonged with a
mean stay of 6 weeks.
Conclusion
FG is an aggressive synergistic fasciitis of the perineum.
It is commonly seen in elderly or debilitated patients.
This disease is no longer considered idiopathic, as an
origin can usually be identified. A perianal source is
now the most common cause of FG. Even with improved
medical care, mortality from FG remains high, particu-
larly among the elderly. This epidemiologic feature
probably results from an increasing proportion of elderly
individuals and an increasing prevalence of high-risk
comorbidities including diabetes, alcoholism, immuno-
suppression, and debilitation.
Imaging modalities can be performed in delineating
the extent of the disease preoperatively in questionable
cases. The principles of management are aggressive
surgical debridement (even repeated debridements 
if clinically indicated), broad-spectrum antibiotics,
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nutritional supplementation, and intensive care. Prompt
surgical extirpation of all nonviable tissue remains the
most important treatment for patients with FG.
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